Funds › JW Asset Management, LLC
JW Asset Management, LLC
13F for Q3 2026, filed Nov 6, 2026. 29 positions worth $239.7M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of JW Asset Management, LLC in the latest 13F quarter?
Using 13F.ai, how has JW Asset Management, LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of JW Asset Management, LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | ESTA Establishment Labs Holdings Inc. | 2.45M | $157.3M | 65.6% | -9.0% | 13F ↗ |
| 2 | SNDK Sandisk Corporation | 7,210 | $12.5M | 5.2% | -7.7% | 13F ↗ |
| 3 | COCO The Vita Coco Company, Inc. | 218,621 | $12.5M | 5.2% | Unchanged | 13F ↗ |
| 4 | DELL Dell Technologies Inc. | 17,500 | $9.4M | 3.9% | +400% | 13F ↗ |
| 5 | MU Micron Technology, Inc. | 7,000 | $7.5M | 3.1% | Unchanged | 13F ↗ |
| 6 | LGND Ligand Pharmaceuticals Incorporated | 15,000 | $4.7M | 2.0% | +275% | 13F ↗ |
| 7 | SN SharkNinja, Inc. | 26,000 | $4.7M | 2.0% | New | 13F ↗ |
| 8 | RL Ralph Lauren Corporation | 12,000 | $4.3M | 1.8% | +20.0% | 13F ↗ |
| 9 | IDR Idaho Strategic Resources, Inc. | 141,197 | $4.0M | 1.6% | Unchanged | 13F ↗ |
| 10 | NVDA NVIDIA Corporation | 15,250 | $3.5M | 1.5% | Unchanged | 13F ↗ |
| 11 | FIVE Five Below, Inc. | 12,418 | $2.7M | 1.1% | +24.2% | 13F ↗ |
| 12 | CAVA CAVA Group, Inc. | 50,000 | $2.7M | 1.1% | Unchanged | 13F ↗ |
| 13 | TVTX Travere Therapeutics, Inc. | 45,000 | $2.6M | 1.1% | +50.0% | 13F ↗ |
| 14 | JAZZ Jazz Pharmaceuticals plc | 11,000 | $2.5M | 1.1% | New | 13F ↗ |
| 15 | KNSA Kiniksa Pharmaceuticals International, plc | 22,000 | $1.6M | 0.7% | New | 13F ↗ |
| 16 | TRLV Trulieve Cannabis Corp. · Sub Vtg Shs | 83,869 | $914.2K | 0.4% | New | 13F ↗ |
| 17 | MRVL Marvell Technology, Inc. | 3,200 | $845.5K | 0.4% | Unchanged | 13F ↗ |
| 18 | URGN UroGen Pharma Ltd. | 20,000 | $812.6K | 0.3% | New | 13F ↗ |
| 19 | TARS Tarsus Pharmaceuticals, Inc. | 9,000 | $707.5K | 0.3% | New | 13F ↗ |
| 20 | Advisorshares Tr Pure Us Cannabis | 155,000 | $700.6K | 0.3% | Unchanged | 13F ↗ |
| 21 | ETON Eton Pharmaceuticals, Inc. | 13,394 | $689.7K | 0.3% | New | 13F ↗ |
| 22 | IMAX Imax Corporation | 11,000 | $602.8K | 0.3% | New | 13F ↗ |
| 23 | CNK Cinemark Holdings Inc Cinemark Holdings, Inc. | 10,500 | $391.6K | 0.2% | New | 13F ↗ |
| 24 | INDV Supernus, Inc. | 10,000 | $358.5K | 0.1% | New | 13F ↗ |
| 25 | UBER Uber Technologies, Inc. | 5,000 | $342.6K | 0.1% | New | 13F ↗ |
| 26 | LQDA Liquidia Corporation | 10,176 | $307.9K | 0.1% | Unchanged | 13F ↗ |
| 27 | HITI High Tide Inc. | 96,643 | $263.8K | 0.1% | Unchanged | 13F ↗ |
| 28 | ACB Aurora Cannabis Inc. | 40,000 | $156.0K | 0.1% | New | 13F ↗ |
| 29 | HRTX Heron Therapeutics, Inc. | 140,863 | $44.2K | <0.1% | -96.2% | 13F ↗ |
Changes since Q2 2026
12 new, 5 added to, 3 trimmed, 4 exited, 9 unchanged. By estimated dollars.
New positions (12)
| SN SharkNinja, Inc. | 26,000 | New | $4.7M |
| JAZZ Jazz Pharmaceuticals plc | 11,000 | New | $2.5M |
| KNSA Kiniksa Pharmaceuticals International, plc | 22,000 | New | $1.6M |
| TRLV Trulieve Cannabis Corp. · Sub Vtg Shs | 83,869 | New | $914.2K |
| URGN UroGen Pharma Ltd. | 20,000 | New | $812.6K |
| TARS Tarsus Pharmaceuticals, Inc. | 9,000 | New | $707.5K |
| ETON Eton Pharmaceuticals, Inc. | 13,394 | New | $689.7K |
| IMAX Imax Corporation | 11,000 | New | $602.8K |
| CNK Cinemark Holdings Inc Cinemark Holdings, Inc. | 10,500 | New | $391.6K |
| INDV Supernus, Inc. | 10,000 | New | $358.5K |
Added to (5)
Trimmed (3)
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 6, 2026 | 13F-HR | 29 | $239.7M | Current | SEC ↗ |
| Q2 2026 | Aug 7, 2026 | 13F-HR | 21 | $319.9M | Current | SEC ↗ |
| Q1 2026 | May 8, 2026 | 13F-HR | 19 | $243.5M | Current | SEC ↗ |
| Q4 2025 | Feb 6, 2026 | 13F-HR | 18 | $307.2M | Current | SEC ↗ |
| Q3 2025 | Nov 7, 2025 | 13F-HR | 17 | $208.4M | Current | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | 13F-HR | 19 | $202.9M | Current | SEC ↗ |
| Q1 2025 | May 9, 2025 | 13F-HR | 18 | $176.6M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer